^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    BCD-178 (pertuzumab biosimilar)

    i
    Associations
    News
    Trials
    Company:
    Biocad
    Drug class:
    HER2 dimerization inhibitor
    Related drugs:
    Associations
    News
    Trials